Trial amounts and timing
retatrutide dosage describes research, not a personal plan
These are the amounts and time spans researchers tested. They aren't directions for taking an unapproved drug.
What did researchers give trial patients?
Researchers tested retatrutide as a weekly injection, and some groups started lower before moving up in planned steps that you cannot treat as a personal schedule outside a trial. Trial staff watched for side effects and changes in body weight, liver fat, and blood sugar [1][2][4]. The trial amounts are not directions for using the drug.
The first human study found a half-life of about six days [4]. That means the amount in blood took about six days to fall by half. Later trials kept the weekly timing while checking health changes [1][2][5]. Retatrutide has no approved form, label, storage rule, or mixing method.
An outside powder or liquid can differ from the drug tested in people, even when the label looks right. Its strength could be false, and it may not be clean enough to inject [6]. You cannot apply the human findings to an unknown vial. This page gives trial facts, not a home plan.
retatrutide dosage
Researchers tried several weekly amounts and watched both health changes and side effects. Some groups moved up in planned steps. The steps belonged to the trial and aren't a schedule for anyone else. Staff knew what each vial held and checked each person.
| Study | Amount each week | How and how long | What doctors checked |
|---|---|---|---|
| Small early Phase 1b trial in type 2 diabetes | 0.5, 1.5, 3, 3/6, and 3/6/9/12 mg in set steps | A shot into fat below the skin, weekly, 12 weeks | Time in blood, sugar, weight, and early harm [4] |
| Mid-stage Phase 2 weight trial | 1, 4, 8, or 12 mg | A shot into fat below the skin, weekly, 48 weeks | Weight and harm [1] |
| Mid-stage Phase 2 type 2 diabetes trial | 0.5–12 mg in steps | A shot into fat below the skin, weekly, 36 weeks | average-sugar blood test, weight, and harm [2] |
| Added fatty-liver study | 1, 4, 8, or 12 mg | A shot into fat below the skin, weekly, 48 weeks | MRI-measured liver fat [5] |
Every amount in the table belonged to one set study plan. People had to meet entry rules and return for health checks. The trial drug came from a known source. This table is a record, not personal directions.
The rows aren't a do-it-yourself ladder. Some groups stayed at one amount, while others moved up. The trials also included people with different health problems. Doctors checked them at different weeks, so the rows aren't equal choices.
What does retatrutide half life mean?
The small Phase 1b study found a half-life of about six days [4]. Half-life doesn't mean the drug is gone after six days. About half the measured amount remains, and half of that falls away later. Weekly shots can therefore overlap in the blood.
Retatrutide is a 39-amino-acid chain, made from small linked pieces. That detail tells scientists how the drug is built, not what it will do for you. A fatty piece makes it cling to albumin, a common protein in your blood. This lets the body remove the drug more slowly. It helps explain why later Phase 2 trials used weekly shots [1][2][4].
Those findings came from the known drug made for human trials. They don't prove how long an outside powder will last. They also can't confirm the strength or storage of such a vial. Copying the trial clock doesn't make an unknown product safe.
Why do the shot and the amount matter?
All published trials gave retatrutide as a shot into the fat under the skin [1][2][4][5]. Higher study amounts brought larger average changes in several health checks. They also brought more stomach trouble and a greater rise in pulse [1]. Help and harm have to be read together.
Planned step-ups let researchers watch how well people could bear the drug. The steps didn't prevent side effects. At the highest amount in the weight trial, 45% had nausea and 18% left the trial [1]. A weight number without those facts would give you only half the answer.
No finished trial here tested retatrutide by mouth. You can't assume a pill would put the same amount into the blood. A change in the drug's form or the way it enters the body can change strength, timing, and risk. Only a new trial could answer that.
Why can't this page say how to reconstitute retatrutide?
Approved directions for mixing retatrutide do not exist. The human trials used a known drug prepared and handled by trial staff. The people taking part weren't handed an unknown powder and a home recipe. No approved drug form, storage rule, or method for mixing a non-trial powder exists.
This page can't give water amounts, mixing sums, filters, or handling steps. Such directions would pretend the powder and its strength were known. They would also pretend the vial had no germs. Trial findings apply to the tested drug, not to a jar with an unchecked label [6].
How can an unapproved vial be stored?
Trial staff controlled how retatrutide was made, labeled, kept, and thrown away. The published work gives no approved home storage label. It can't support a fridge range, a date after mixing, or a rule about light. It also can't promise that a mixed drug stays whole.
Looks won't tell you whether a shot is safe. A clear liquid can still hold germs or pieces from germs that can make you ill. A good-looking vial also doesn't prove the amount on the label is right. Trial doctors can track a drug only when they know what is in it.
The answer is narrow but honest. The trials tested a known drug under close control. Their results don't tell you how to store or handle an outside product. No appearance test can close that gap.